UNITEDHEALTH GROUP INC (UNH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 40B 80B 120B Q3 '16: 46.3B Q4 '16: 47.5B Q1 '17: 48.7B Q2 '17: 50.1B Q3 '17: 50.3B Q4 '17: 52.1B Q1 '18: 55.2B Q2 '18: 56.1B Q3 '18: 56.6B Q4 '18: 58.4B Q1 '19: 60.3B Q2 '19: 60.6B Q3 '19: 60.4B Q4 '19: 60.9B Q1 '20: 64.4B Q2 '20: 62.1B Q3 '20: 65.1B Q4 '20: 65.5B Q1 '21: 70.2B Q2 '21: 71.3B Q3 '21: 72.3B Q4 '21: 73.7B Q1 '22: 80.1B Q2 '22: 80.3B Q3 '22: 80.9B Q4 '22: 82.8B Q1 '23: 91.9B Q2 '23: 92.9B Q3 '23: 92.4B Q4 '23: 94.4B Q1 '24: 99.8B Q2 '24: 98.9B Q3 '24: 100.8B Q4 '24: 100.8B Q1 '25: 109.6B Q2 '25: 111.6B Q3 '25: 113.2B Q4 '25: 113.2B Q1 '26: 111.7B Q2 '26: 112B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

0 3.5B 7B 10.5B Q3 '16: 3.6B Q4 '16: 3.2B Q1 '17: 3.4B Q2 '17: 3.7B Q3 '17: 4.1B Q4 '17: 4B Q1 '18: 4.1B Q2 '18: 4.2B Q3 '18: 4.6B Q4 '18: 4.5B Q1 '19: 4.8B Q2 '19: 4.7B Q3 '19: 5B Q4 '19: 5.1B Q1 '20: 5B Q2 '20: 9.2B Q3 '20: 4.7B Q4 '20: 3.5B Q1 '21: 6.7B Q2 '21: 6B Q3 '21: 5.7B Q4 '21: 5.5B Q1 '22: 7B Q2 '22: 7.1B Q3 '22: 7.5B Q4 '22: 6.9B Q1 '23: 8.1B Q2 '23: 8.1B Q3 '23: 8.5B Q4 '23: 7.7B Q1 '24: 7.9B Q2 '24: 7.9B Q3 '24: 8.7B Q4 '24: 7.8B Q1 '25: 9.1B Q2 '25: 5.2B Q3 '25: 4.3B Q4 '25: 380M Q1 '26: 9B Q2 '26: 8B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-2.5B 0 2.5B 5B 7.5B Q3 '16: 2B Q4 '16: 1.7B Q1 '17: 2.2B Q2 '17: 2.3B Q3 '17: 2.5B Q4 '17: 3.6B Q1 '18: 2.8B Q2 '18: 2.9B Q3 '18: 3.2B Q4 '18: 3B Q1 '19: 3.5B Q2 '19: 3.3B Q3 '19: 3.5B Q4 '19: 3.5B Q1 '20: 3.4B Q2 '20: 6.6B Q3 '20: 3.2B Q4 '20: 2.2B Q1 '21: 4.9B Q2 '21: 4.3B Q3 '21: 4.1B Q4 '21: 4.1B Q1 '22: 5B Q2 '22: 5.1B Q3 '22: 5.3B Q4 '22: 4.8B Q1 '23: 5.6B Q2 '23: 5.5B Q3 '23: 5.8B Q4 '23: 5.5B Q1 '24: -1.4B Q2 '24: 4.2B Q3 '24: 6.1B Q4 '24: 5.5B Q1 '25: 6.3B Q2 '25: 3.4B Q3 '25: 2.3B Q4 '25: 10M Q1 '26: 6.3B Q2 '26: 5.5B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 6B 12B 18B Q3 '16: 7B Q4 '16: 7.8B Q1 '17: 7B Q2 '17: 7.3B Q3 '17: 7.4B Q4 '17: 7.8B Q1 '18: 8.5B Q2 '18: 8.4B Q3 '18: 8.5B Q4 '18: 8.7B Q1 '19: 8.5B Q2 '19: 8.4B Q3 '19: 9B Q4 '19: 9.3B Q1 '20: 10B Q2 '20: 10B Q3 '20: 10.2B Q4 '20: 11.5B Q1 '21: 10.2B Q2 '21: 10.4B Q3 '21: 10.7B Q4 '21: 11.3B Q1 '22: 11.4B Q2 '22: 11.7B Q3 '22: 11.7B Q4 '22: 13B Q1 '23: 13.6B Q2 '23: 13.8B Q3 '23: 13.9B Q4 '23: 13.3B Q1 '24: 14.1B Q2 '24: 13.2B Q3 '24: 13.3B Q4 '24: 12.5B Q1 '25: 13.6B Q2 '25: 13.8B Q3 '25: 15.2B Q4 '25: 17B Q1 '26: 15.4B Q2 '26: 14.3B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

0 7B 14B 21B Q3 '15: 2.8B Q4 '15: 3.5B Q1 '16: 2.3B Q2 '16: 1.7B Q3 '16: 7.2B Q1 '17: 6.5B Q2 '17: 2.2B Q3 '17: 7.5B Q1 '18: 8.4B Q2 '18: 4B Q3 '18: 941M Q4 '18: 2.4B Q1 '19: 3.2B Q2 '19: 5.9B Q3 '19: 3.1B Q4 '19: 6.2B Q1 '20: 2.9B Q2 '20: 10B Q3 '20: 3.1B Q4 '20: 6.1B Q1 '21: 6B Q2 '21: 5.5B Q3 '21: 7.6B Q4 '21: 3.2B Q1 '22: 5.3B Q2 '22: 6.9B Q3 '22: 18.5B Q1 '23: 16.3B Q2 '23: 11B Q3 '23: 6.9B Q1 '24: 1.1B Q2 '24: 6.7B Q3 '24: 13.9B Q4 '24: 2.4B Q1 '25: 5.5B Q2 '25: 7.2B Q3 '25: 5.9B Q4 '25: 1.1B Q1 '26: 8.9B Q2 '26: 11.1B Q3 '16 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q3 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

0 7B 14B 21B Q3 '15: 2.4B Q4 '15: 3B Q1 '16: 1.9B Q2 '16: 1.3B Q3 '16: 6.8B Q1 '17: 5.9B Q2 '17: 1.8B Q3 '17: 7.1B Q1 '18: 7.9B Q2 '18: 3.5B Q3 '18: 396M Q4 '18: 1.8B Q1 '19: 2.7B Q2 '19: 5.5B Q3 '19: 2.7B Q4 '19: 5.6B Q1 '20: 2.5B Q2 '20: 9.6B Q3 '20: 2.6B Q4 '20: 5.5B Q1 '21: 5.4B Q2 '21: 5B Q3 '21: 7B Q4 '21: 2.5B Q1 '22: 4.8B Q2 '22: 6.2B Q3 '22: 17.8B Q1 '23: 15.6B Q2 '23: 10.2B Q3 '23: 6.1B Q1 '24: 401M Q2 '24: 5.9B Q3 '24: 13B Q4 '24: 1.5B Q1 '25: 4.6B Q2 '25: 6.3B Q3 '25: 5.1B Q4 '25: 160M Q1 '26: 8.1B Q2 '26: 10.3B Q3 '16 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q3 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 350M 700M 1.1B Q2 '13: 1B Q3 '13: 1B Q1 '14: 996M Q2 '14: 991M Q3 '14: 982M Q1 '15: 969M Q2 '15: 966M Q3 '15: 967M Q1 '16: 967M Q2 '16: 967M Q3 '16: 969M Q1 '17: 975M Q2 '17: 985M Q3 '17: 989M Q1 '18: 987M Q2 '18: 982M Q3 '18: 983M Q1 '19: 975M Q2 '19: 964M Q3 '19: 963M Q1 '20: 962M Q2 '20: 960M Q3 '20: 962M Q1 '21: 957M Q2 '21: 956M Q3 '21: 955M Q1 '22: 954M Q2 '22: 950M Q3 '22: 948M Q1 '23: 943M Q2 '23: 940M Q3 '23: 936M Q1 '24: 922M Q2 '24: 928M Q3 '24: 930M Q1 '25: 918M Q2 '25: 910M Q3 '25: 908M Q1 '26: 910M Q2 '26: 906M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 9.00 18.00 27.00 Q3 '16: 6.77 Q4 '16: 7.25 Q1 '17: 7.81 Q2 '17: 8.32 Q3 '17: 8.80 Q4 '17: 10.72 Q1 '18: 11.36 Q2 '18: 12.02 Q3 '18: 12.75 Q4 '18: 12.19 Q1 '19: 12.88 Q2 '19: 13.32 Q3 '19: 13.75 Q4 '19: 14.33 Q1 '20: 14.29 Q2 '20: 17.78 Q3 '20: 17.41 Q4 '20: 16.03 Q1 '21: 17.59 Q2 '21: 15.14 Q3 '21: 16.12 Q4 '21: 18.08 Q1 '22: 18.27 Q2 '22: 19.15 Q3 '22: 20.42 Q4 '22: 21.19 Q1 '23: 21.87 Q2 '23: 22.35 Q3 '23: 23.04 Q4 '23: 23.86 Q1 '24: 16.38 Q2 '24: 15.10 Q3 '24: 15.37 Q4 '24: 15.50 Q1 '25: 23.88 Q2 '25: 23.08 Q3 '25: 19.16 Q4 '25: 13.20 Q1 '26: 13.25 Q2 '26: 15.55 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.